Guiyang Xintian Pharmaceutical Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 525.56 million compared to CNY 524.1 million a year ago. Revenue was CNY 525.91 million compared to CNY 524.54 million a year ago.

Net income was CNY 46.33 million compared to CNY 57.45 million a year ago. Basic earnings per share from continuing operations was CNY 0.1997 compared to CNY 0.2478 a year ago. Diluted earnings per share from continuing operations was CNY 0.1887 compared to CNY 0.2327 a year ago.